Prescribing of hormone therapy in menopause and postmenopause.
This article describes the use and prescribing of menopausal and postmenopausal hormone therapy (HT) in one example country, Finland, and the trends and levels of HT use in other western countries for comparison. Previously published studies were reviewed and reanalyzed, and some additional unpublished data from Finnish surveys were compiled. The use of HT increased in Finland up to 1994. In Finland the initiative for HT use came more often from physicians than women themselves, physicians valued HT more than women, women's period of use of HT was shorter than physicians' recommendations, women's reasons for using HT were usually to treat symptoms, but physicians considered HT also useful in the prevention of later diseases. Gynecologists were more favorable toward HT than other physicians. HT has become common in very different times in different countries, but with the exception of the US experience in the 1970s, the trend has been towards increasing use. One motivation to do surveys on physicians' prescribing or women's use of HT has been to facilitate HT use. The large variation in HT use may reflect the uncertainty concerning its true value. The reasons for the large-scale prevention with HT have not been systematically studied, but it is likely due to various social and commercial forces.
Hemminki
E
E
National Research and Development Centre for Welfare and Health, Health Services Research Unit, Helsinki, Finland.
Topo
P
P
D002979:Climacteric; D003431:Cross-Cultural Comparison; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000706:statistics & numerical data*; D005060:Europe; D005260:Female; D005387:Finland; D006801:Humans; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D012959:Socioeconomic Factors; D013997:Time Factors; D014481:United States